Fundz

Caliway Closes Oversubscribed Capital Raise And Secures Over $100M To Advance Cbl-514 Pivotal Phase 3 Study In Subcutaneous Fat Reduction

PRIVATEDec 16, 2023

Round Type

Funding Round

TaiwanPharmaceutical Manufacturing

Description

Caliway Biopharmaceuticals (Caliway) announced that it has closed an oversubscribed capital raise, securing over $100M by issuing 8 million new shares.

Quick answer

Caliway Biopharmaceuticals raised an undisclosed amount in a Funding Round round, dated December 16, 2023. Caliway Biopharmaceuticals is based in Taiwan.

How much did Caliway Biopharmaceuticals raise?
Caliway Biopharmaceuticals raised an undisclosed amount in a Funding Round round on December 16, 2023.
What does Caliway Biopharmaceuticals do?
Caliway Biopharmaceuticals (Caliway) is a Taiwan-headquartered, clinical-stage biopharmaceutical company driven to breakthrough drug discovery of novel small-molecule therapeutics.
Where is Caliway Biopharmaceuticals based and how big is it?
Caliway Biopharmaceuticals is based in Taiwan.
Who are the decision-makers at Caliway Biopharmaceuticals?
Fundz holds 1 contact at Caliway Biopharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical Manufacturing around the same time

Companies in the same sectors as Caliway Biopharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • COUR Pharmaceuticals raised $105M (Series A) on January 30, 2024.
  • 3Daughters raised $2M (Seed) on January 22, 2024.
  • Comanche Biopharma raised $75M (Series B) on January 18, 2024.
  • Radionetics Oncology raised an undisclosed amount on January 5, 2024.
  • Radionetics Oncology raised $53M (Series A) on January 3, 2024.
  • Centrexion Therapeutics raised $3.3M (Seed) on December 28, 2023.

Who to call at Caliway Biopharmaceuticals, and when

A new round usually means Caliway Biopharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Caliway Biopharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Caliway Biopharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Caliway Biopharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Caliway Biopharmaceuticals

Location

Taiwan

About

Caliway Biopharmaceuticals (Caliway) is a Taiwan-headquartered, clinical-stage biopharmaceutical company driven to breakthrough drug discovery of novel small-molecule therapeutics. Listed on the emerging stock market in Taiwan (TPEX6919), Caliway aims to become an innovative pharmaceutical leader in aesthetic medicine and inflammatory disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Caliway Biopharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Caliway Biopharmaceuticals's next move

See what Strategic adds

Caliway Biopharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.